{"article_title": "Analyst on PPACA subsidy ruling: Calm down", "article_keywords": ["vs", "ppaca", "brian", "companies", "subsidy", "wright", "program", "calm", "unlikely", "analyst", "ruling"], "article_url": "http://www.lifehealthpro.com/2016/05/16/analyst-on-ppaca-subsidy-ruling-calm-down", "article_text": "Brian Wright says the House vs. Burwell ruling is unlikely to have much practical effect on the companies he tracks for at least a year. (TS/John Kroetch)\n\nA securities analyst says the new federal court ruling against a Patient Protection and Affordable Care Act (PPACA) subsidy program is probably more of a buying opportunity for investors than a calamity for insurers.\n\nIn a new commentary, Sterne Agee CRT Analyst Brian Wright, who follows health insurers and hospital companies, looks at the possible effects of the District of Columbia decision on the PPACA cost-sharing reduction subsidy program.", "article_metadata": {"sailthru.author": "Allison Bell", "description": "Brian Wright says insurers should get through 2017 open enrollment in good shape.", "og": {"url": "http://www.lifehealthpro.com/2016/05/16/analyst-on-ppaca-subsidy-ruling-calm-down", "image": "http://media.lifehealthpro.com/lifehealthpro/article/2016/05/13/1104-old-law-books--96356295-john-kroetch-738x415t.jpg", "type": "website", "description": "Brian Wright says insurers should get through 2017 open enrollment in good shape.", "title": "Analyst on PPACA subsidy ruling: Calm down"}, "twitter": {"description": "Brian Wright says insurers should get through 2017 open enrollment in good shape.", "title": "Analyst on PPACA subsidy ruling: Calm down", "image": {"src": "http://media.lifehealthpro.com/lifehealthpro/article/2016/05/13/1104-old-law-books--96356295-john-kroetch-738x415t-crop-120x120.jpg"}, "creator": "@LifeHealthPro", "site": "@LifeHealthPro", "card": "summary"}, "sailthru.date": "2016-05-16", "sailthru.tags": "lifehealthpro, article, 57361760140ba0a02ef01625, News, Individual Health,Employee Benefits, house vs. burwell,cost-sharing reduction", "keywords": "Individual Health, Employee Benefits, cost-sharing reduction, house vs. burwell", "sniply-options": "block", "sailthru.image.full": "http://media.lifehealthpro.com/lifehealthpro/article/2016/05/13/1104-old-law-books--96356295-john-kroetch-738x415t.jpg", "viewport": "width=device-width, minimum-scale=1.0, maximum-scale=1.0, user-scalable=0"}, "_id": "\"57477af46914bd0286fdf32e\"", "article_summary": "(TS/John Kroetch)A securities analyst says the new federal court ruling against a Patient Protection and Affordable Care Act (PPACA) subsidy program is probably more of a buying opportunity for investors than a calamity for insurers.\nIn a new commentary, Sterne Agee CRT Analyst Brian Wright, who follows health insurers and hospital companies, looks at the possible effects of the District of Columbia decision on the PPACA cost-sharing reduction subsidy program.\nBrian Wright says the House vs. Burwell ruling is unlikely to have much practical effect on the companies he tracks for at least a year."}